Abbott Laboratories
ABT
#85
Rank
NZ$323.47 B
Marketcap
NZ$186.16
Share price
-1.86%
Change (1 day)
-21.90%
Change (1 year)
Categories

Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.

EPS for Abbott Laboratories (ABT)

EPS in 2025 (TTM): NZ$6.41

According to Abbott Laboratories's latest financial reports the company's current EPS (TTM) is NZ$6.31. In 2024 the company made an earnings per share (EPS) of NZ$13.02 an increase over its 2023 EPS that were of NZ$5.55.

EPS history for Abbott Laboratories from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$6.41-50.74%
2024NZ$13.02134.51%
2023NZ$5.55-23.23%
2022NZ$7.237.5%
2021NZ$6.7357.41%
2020NZ$4.2721.54%
2019NZ$3.5254.75%
2018NZ$2.27389.07%
2017NZ$0.46-71.01%
2016NZ$1.60-68.01%
2015NZ$5.0196.13%
2014NZ$2.55-8.64%
2013NZ$2.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.75 197.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.39 96.32%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.29-63.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.25-1.04%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Thermo Fisher Scientific
TMO
NZ$29.92 374.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
NZ$3.30-47.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
NZ$4.09-35.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.00-20.78%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$9.01 42.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$6.34 0.51%๐Ÿ‡ฌ๐Ÿ‡ง UK